Sphera Funds Management Ltd. Vincerx Pharma, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-649,694 Reduced 90.22%	70,467 $93,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	65,589 Added 10.02%	720,161 $7.34 Million
Q3 2021 Nov 15, 2021	BUY	$0.0 - $0.0 $0 - $0	427,122 Added 187.79%	654,572 $10.6 Million
Q2 2021 Aug 17, 2021	BUY	$0.0 - $27.0 $0 - $3.61 Million	133,742 Added 142.72%	227,450 $2.96 Million
Q1 2021 May 17, 2021	BUY	$22.6 - $31.0 $1.07 Million - $1.46 Million	47,243 Added 101.67%	93,708 $1.81 Million
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $597,075 - $926,976	46,465 New	46,465 $972,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.